Cargando…

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome

A 7-year-old boy presented at our hospital with syncope. At birth, electrocardiography had shown a long QT interval with torsade de pointes (TdP). Congenital long QT syndrome (LQTS) had been diagnosed by genetic testing, and was successfully controlled with oral propranolol. At age 7, TdP had recurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugiyama, Hirotaro, Tachibana, Motomi, Morita, Hiroshi, Nishii, Nobuhiro, Miyoshi, Akihito, Sugiyama, Hiroyasu, Nakagawa, Koji, Watanabe, Atsuyuki, Nakamura, Kazufumi, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459415/ https://www.ncbi.nlm.nih.gov/pubmed/28607621 http://dx.doi.org/10.1016/j.joa.2016.10.561

Ejemplares similares

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
por: Nishii, Nobuhiro, et al.
Publicado: (2017)

Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting
por: Nishii, Nobuhiro, et al.
Publicado: (2017)

Successful radiofrequency catheter ablation of a premature ventricular contraction triggering ventricular fibrillation in a patient with short QT syndrome
por: Morimoto, Yoshimasa, et al.
Publicado: (2019)

Open chest epicardial mapping in an asymptomatic patient with Brugada syndrome
por: Watanabe, Atsuyuki, et al.
Publicado: (2019)

A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring
por: Morimoto, Yoshimasa, et al.
Publicado: (2019)

Syncope and loss of consciousness after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: Prevalence and characteristics in long-term follow-up
por: Asada, Saori, et al.
Publicado: (2023)

Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome
por: Ueoka, Akira, et al.
Publicado: (2018)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

Usefulness of right ventriculography compared with computed tomography for ruling out the possibility of lead perforation before lead extraction
por: Asada, Saori, et al.
Publicado: (2021)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

Local Left Ventricular Epicardial J Waves and Late Potentials in Brugada Syndrome Patients with Inferolateral Early Repolarization Pattern
por: Nagase, Satoshi, et al.
Publicado: (2017)

Prognosis after lead extraction in patients with cardiac implantable electronic devices infection: Comparison of lead‐related infective endocarditis with pocket infection in a Japanese single‐center experience
por: Nishii, Nobuhiro, et al.
Publicado: (2019)

Recording of isolated very delayed potentials on the right ventricular epicardium in a patient with Brugada syndrome
por: Watanabe, Atsuyuki, et al.
Publicado: (2017)

Epicardial Cardioverter Defibrillator Implantation due to Post-Fontan Ventricular Tachycardia
por: Papakonstantinou, Nikolaos A, et al.
Publicado: (2020)

Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
por: Toda, Hironobu, et al.
Publicado: (2019)

Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator
por: Younis, Arwa, et al.
Publicado: (2020)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
por: Nishii, Nobuhiro, et al.
Publicado: (2021)

Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
por: Miyamoto, Masakazu, et al.
Publicado: (2023)

Late Development of a Bronchocutaneous Fistula due to an Epicardial Cardioverter-Defibrillator Lead
por: Patris, Vasileios, et al.
Publicado: (2015)

Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child
por: de Asmundis, Carlo, et al.
Publicado: (2018)

Percutaneous lead extraction for patients with large vegetations using an unusual technique
por: Nishii, Nobuhiro, et al.
Publicado: (2018)

SMART pass will prevent inappropriate operation of S‐ICD
por: Tachibana, Motomi, et al.
Publicado: (2018)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable cardioverter defibrillator therapy for secondary prevention in spontaneous coronary artery dissection: to place or not to place? This is the matter
por: Scagliola, Riccardo, et al.
Publicado: (2020)

A new approach for implantation of a cardiac resynchronization therapy–defibrillator in a patient with bilateral pectoral neurostimulation devices
por: Tsukuda, Saori, et al.
Publicado: (2018)

Effectiveness of changing conventional implantable cardioverter-defibrillator settings to intrinsic antitachycardia pacing–like settings in the treatment of ventricular tachycardia in patients with cardiac failure
por: Tachibana, Motomi, et al.
Publicado: (2022)

Significance of Exercise‐Related Ventricular Arrhythmias in Patients With Brugada Syndrome
por: Morita, Hiroshi, et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Successful ablation of a superior fast-slow atrioventricular reentrant tachycardia in a patient with congenitally corrected transposition of great arteries
por: Kawada, Satoshi, et al.
Publicado: (2021)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Influence of secondary neutrons induced by proton radiotherapy for cancer patients with implantable cardioverter defibrillators
por: Hashimoto, Takayuki, et al.
Publicado: (2012)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
por: Nakao, Yasuhisa, et al.
Publicado: (2020)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_74l7h6qh5p4046p56jsqv6o9ja